tiprankstipranks
Trending News
More News >
Chemours price target lowered to $17 from $25 at RBC Capital
PremiumThe FlyChemours price target lowered to $17 from $25 at RBC Capital
26d ago
Chemours price target lowered to $16 from $19 at Barclays
Premium
The Fly
Chemours price target lowered to $16 from $19 at Barclays
1M ago
Chemours Company: Undervalued Growth Potential Driven by TSS Segment and Market Opportunities
Premium
Ratings
Chemours Company: Undervalued Growth Potential Driven by TSS Segment and Market Opportunities
1M ago
Chemours, NTT Data, Hibiya Engineering partner on Opteon 2P50 trial
PremiumThe FlyChemours, NTT Data, Hibiya Engineering partner on Opteon 2P50 trial
2M ago
Chemours Company: Hold Rating Amid Board Changes and PFAS Challenges
Premium
Ratings
Chemours Company: Hold Rating Amid Board Changes and PFAS Challenges
2M ago
Chemours price target lowered to $19 from $23 at Barclays
Premium
The Fly
Chemours price target lowered to $19 from $23 at Barclays
2M ago
Chemours Company Reports 2024 Financial Results
PremiumCompany AnnouncementsChemours Company Reports 2024 Financial Results
3M ago
Chemours Earnings Call: Mixed Sentiments and Strategic Growth
Premium
Company Announcements
Chemours Earnings Call: Mixed Sentiments and Strategic Growth
3M ago
Morning Movers: Medtronic dips following third quarter results
Premium
The Fly
Morning Movers: Medtronic dips following third quarter results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100